Literature DB >> 21308681

Amplification of cytokine production through synergistic activation of NFAT and AP-1 following stimulation of mast cells with antigen and IL-33.

Marcus V Andrade1, Shoko Iwaki, Catherine Ropert, Ricardo T Gazzinelli, Jose R Cunha-Melo, Michael A Beaven.   

Abstract

IL-33 is associated with atopic and autoimmune diseases and, as reported here, it interacts synergistically with Ag to markedly enhance production of inflammatory cytokines in rodent mast cells even in the absence of degranulation. Investigation of the underlying mechanisms revealed that synergy in signaling occurred at the level of TGF-β-activated kinase 1, which was then transmitted downstream through JNK, p38 MAP kinase, and AP-1. Stimulation of the Ca(2+) /calcineurin/NFAT pathway by Ag, which IL-33 did not, was critical for the synergy between Ag and IL-33. For example, selective stimulation of the NFAT pathway by thapsigargin also markedly enhanced responses to IL-33 in a calcineurin-dependent manner. As indicated by luciferase-reporter assays, IL-33 failed to stimulate the transcriptional activities of NFAT and AP-1 but augmented the activation of these transcription factors by Ag or thapsigargin. Robust stimulation of NF-κB transcriptional activity by IL-33 was also essential for the synergy. These and pharmacologic data suggested that the enhanced production of cytokines resulted in part from amplification of the activation of AP-1 and NFAT as well as co-operative interactions among transcription factors. IL-33 may retune mast cell responses to Ag toward enhanced cytokine production and thus determine the symptoms and severity of Ag-dependent allergic and autoimmune diseases.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21308681      PMCID: PMC3085255          DOI: 10.1002/eji.201040718

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  56 in total

Review 1.  Molecular regulation of mast cell activation.

Authors:  Juan Rivera; Alasdair M Gilfillan
Journal:  J Allergy Clin Immunol       Date:  2006-06       Impact factor: 10.793

2.  IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex.

Authors:  Alissa A Chackerian; Elizabeth R Oldham; Erin E Murphy; Jochen Schmitz; Stefan Pflanz; Robert A Kastelein
Journal:  J Immunol       Date:  2007-08-15       Impact factor: 5.422

3.  Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells.

Authors:  Zoulfia Allakhverdi; Dirk E Smith; Michael R Comeau; Guy Delespesse
Journal:  J Immunol       Date:  2007-08-15       Impact factor: 5.422

Review 4.  G protein-coupled receptors and the modification of FcepsilonRI-mediated mast cell activation.

Authors:  Hye Sun Kuehn; Alasdair M Gilfillan
Journal:  Immunol Lett       Date:  2007-09-18       Impact factor: 3.685

Review 5.  Regulation of the mast cell response to the type 1 Fc epsilon receptor.

Authors:  Jakub Abramson; Israel Pecht
Journal:  Immunol Rev       Date:  2007-06       Impact factor: 12.988

6.  Btk plays a crucial role in the amplification of Fc epsilonRI-mediated mast cell activation by kit.

Authors:  Shoko Iwaki; Christine Tkaczyk; Anne B Satterthwaite; Kristina Halcomb; Michael A Beaven; Dean D Metcalfe; Alasdair M Gilfillan
Journal:  J Biol Chem       Date:  2005-09-21       Impact factor: 5.157

7.  IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo.

Authors:  Virginie Carriere; Lucie Roussel; Nathalie Ortega; Delphine-Armelle Lacorre; Laure Americh; Luc Aguilar; Gérard Bouche; Jean-Philippe Girard
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-21       Impact factor: 11.205

Review 8.  IL-33: a sheep in wolf's clothing?

Authors:  Massimo Gadina; Caroline A Jefferies
Journal:  Sci STKE       Date:  2007-06-12

9.  IL-33 can promote survival, adhesion and cytokine production in human mast cells.

Authors:  Motoyasu Iikura; Hajime Suto; Naoki Kajiwara; Keisuke Oboki; Tatsukuni Ohno; Yoshimichi Okayama; Hirohisa Saito; Stephen J Galli; Susumu Nakae
Journal:  Lab Invest       Date:  2007-08-13       Impact factor: 5.662

10.  The Bcl10-Malt1 complex segregates Fc epsilon RI-mediated nuclear factor kappa B activation and cytokine production from mast cell degranulation.

Authors:  Stefanie Klemm; Jan Gutermuth; Lothar Hültner; Tim Sparwasser; Heidrun Behrendt; Christian Peschel; Tak W Mak; Thilo Jakob; Jürgen Ruland
Journal:  J Exp Med       Date:  2006-01-23       Impact factor: 14.307

View more
  37 in total

1.  Effects of interleukin-33 on cardiac fibroblast gene expression and activity.

Authors:  Jinyu Zhu; Wayne Carver
Journal:  Cytokine       Date:  2012-03-23       Impact factor: 3.861

Review 2.  Mast cell activity in the healing wound: more than meets the eye?

Authors:  Brian C Wulff; Traci A Wilgus
Journal:  Exp Dermatol       Date:  2013-06-27       Impact factor: 3.960

3.  Didox (3,4-dihydroxybenzohydroxamic acid) suppresses IL-33-induced cytokine production in primary mouse mast cells.

Authors:  Heather L Caslin; Jamie Josephine Avila McLeod; Andrew J Spence; Amina Abdul Qayum; Elizabeth Motunrayo Kolawole; Marcela T Taruselli; Anuya Paranjape; Howard L Elford; John J Ryan
Journal:  Cell Immunol       Date:  2017-07-11       Impact factor: 4.868

4.  Regulation of Fc∈RI signaling in mast cells by G protein-coupled receptor kinase 2 and its RH domain.

Authors:  Hariharan Subramanian; Kshitij Gupta; Narayanan Parameswaran; Hydar Ali
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

5.  Hepatitis C virus-host interactions: Etiopathogenesis and therapeutic strategies.

Authors:  Mohamed Hassan; Denis Selimovic; Abdelouahid El-Khattouti; Hanan Ghozlan; Youssef Haikel; Ola Abdelkader
Journal:  World J Exp Med       Date:  2012-04-20

6.  IL-33 induces a hyporesponsive phenotype in human and mouse mast cells.

Authors:  Mi-Yeon Jung; Daniel Smrž; Avanti Desai; Geethani Bandara; Tomonobu Ito; Shoko Iwaki; Jeong-Han Kang; Marcus V Andrade; Susana C Hilderbrand; Jared M Brown; Michael A Beaven; Dean D Metcalfe; Alasdair M Gilfillan
Journal:  J Immunol       Date:  2012-12-17       Impact factor: 5.422

7.  Knockout of the Trpc1 gene reveals that TRPC1 can promote recovery from anaphylaxis by negatively regulating mast cell TNF-α production.

Authors:  Nevenka Medic; Avanti Desai; Ana Olivera; Joel Abramowitz; Lutz Birnbaumer; Michael A Beaven; Alasdair M Gilfillan; Dean D Metcalfe
Journal:  Cell Calcium       Date:  2013-03-13       Impact factor: 6.817

8.  Dexamethasone rapidly suppresses IL-33-stimulated mast cell function by blocking transcription factor activity.

Authors:  Anuya Paranjape; Oksana Chernushevich; Amina Abdul Qayum; Andrew J Spence; Marcela T Taruselli; Daniel Abebayehu; Brian O Barnstein; Jamie Josephine Avila McLeod; Bianca Baker; Gurjas S Bajaj; Alena P Chumanevich; Carole A Oskeritzian; John J Ryan
Journal:  J Leukoc Biol       Date:  2016-07-21       Impact factor: 4.962

9.  Activated mast cells synthesize and release soluble ST2-a decoy receptor for IL-33.

Authors:  Geethani Bandara; Michael A Beaven; Ana Olivera; Alasdair M Gilfillan; Dean D Metcalfe
Journal:  Eur J Immunol       Date:  2015-09-09       Impact factor: 5.532

10.  IL-33/ST2 signalling contributes to carrageenin-induced innate inflammation and inflammatory pain: role of cytokines, endothelin-1 and prostaglandin E2.

Authors:  A C Zarpelon; T M Cunha; J C Alves-Filho; L G Pinto; S H Ferreira; I B McInnes; D Xu; F Y Liew; F Q Cunha; W A Verri
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.